<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04231240</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL19_0381</org_study_id>
    <nct_id>NCT04231240</nct_id>
  </id_info>
  <brief_title>Correlation Between Hemochron and Istat in Cardiac Surgery (CHIC Study)</brief_title>
  <acronym>CHIC</acronym>
  <official_title>Correlation Between Hemochron and Istat in Cardiac Surgery (CHIC Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiac surgery needs the use of cardiopulmonary bypass. During this time, it is necessary to&#xD;
      prevent thrombosis with high level of heparin and to control the good efficiency with a point&#xD;
      of care test. Investigators want to test if two different devices, Hemochron and Istat, are&#xD;
      giving similar results.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The management of the extracorporeal circulation (ECC) for cardiac surgery requires massive&#xD;
      anticoagulation of the circuit by heparinization at 300 IU / kg of unfractionated heparin&#xD;
      (HNF). To ensure an adequate level of safety, it is necessary to monitor the effectiveness of&#xD;
      this dose of NHF. Several point of care monitors measuring activated coagulation time (ACT)&#xD;
      are available on the market. Among these are the Hemochron (currently used routinely in the&#xD;
      institution) and the IStat. These two monitors have been compared in adult cardiac surgery&#xD;
      without deep hypothermia, but there is no comparative study in pediatric cardiac surgery.&#xD;
&#xD;
      The result of the ACT being dependent, in addition to heparinization, the platelet count, the&#xD;
      fibrinogen level and the body temperature, it is therefore necessary to test the approval and&#xD;
      the interchangeability between the monitors in different clinical situations .&#xD;
&#xD;
      The objective of this study is to reproduce the results published in adults and to compare&#xD;
      these two monitors in pediatrics.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 17, 2020</start_date>
  <completion_date type="Actual">March 2, 2021</completion_date>
  <primary_completion_date type="Actual">March 2, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Agreement of ACT measurement with Istat and Hemochron</measure>
    <time_frame>Maximum 6 hours (time of surgery)</time_frame>
    <description>Investigators will use linear regression correlation, ROC curves analysis&#xD;
Istat and Hemochron will be measured at 5 time points :&#xD;
induction,&#xD;
2 minutes after heparin loading,&#xD;
10 minutes after the stat of cardiopulmonary bypass or after heparin,&#xD;
30 minutes after the start of cardiopulmonary bypass or after heparin,&#xD;
2 minutes after protamin</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Interchangeability of ACT measurement with Istat and Hemochron</measure>
    <time_frame>Maximum 6 hours (time of surgery)</time_frame>
    <description>Investigators will use linear regression correlation, ROC curves analysis&#xD;
Istat and Hemochron will be measured at 5 time points :&#xD;
induction,&#xD;
2 minutes after heparin loading,&#xD;
10 minutes after the stat of cardiopulmonary bypass or after heparin,&#xD;
30 minutes after the start of cardiopulmonary bypass or after heparin,&#xD;
2 minutes after protamin</description>
  </primary_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Cardiac Event</condition>
  <arm_group>
    <arm_group_label>Adult cardiac surgery with normothermia</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Adult cardiac surgery with hypothermia</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Pediatric cardiac surgery with normothermia</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Pediatric cardiac surgery with hypothermia</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Adult cardiac surgery without cardiopulmonary bypass</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Measure of ACT with IStat</intervention_name>
    <description>Measure of ACT with a point of care device named IStat</description>
    <arm_group_label>Adult cardiac surgery with hypothermia</arm_group_label>
    <arm_group_label>Adult cardiac surgery with normothermia</arm_group_label>
    <arm_group_label>Adult cardiac surgery without cardiopulmonary bypass</arm_group_label>
    <arm_group_label>Pediatric cardiac surgery with hypothermia</arm_group_label>
    <arm_group_label>Pediatric cardiac surgery with normothermia</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adults and children with cardiac surgery with or without cardiopulmonary bypass supported&#xD;
        in the Department of Anesthesia - Resuscitation of the Louis Pradel Hospital (Lyon,&#xD;
        France).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  adults or children&#xD;
&#xD;
          -  Supported in the Department of Anesthesia - Resuscitation of the Louis Pradel Hospital&#xD;
             (Lyon, France) for cardiac surgery with or without cardiopulmonary bypass&#xD;
&#xD;
          -  Patient or Parents / Holders of parental authority informed and not opposed to&#xD;
             participate in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patient with heparin-induced thrombocytopenia&#xD;
&#xD;
          -  patient receiving antiplatelet therapy targeting GpIIbIIIa receptors&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Service d'Anesthésie - Réanimation de l'hôpital Louis Pradel - HCL</name>
      <address>
        <city>Bron</city>
        <zip>69500</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>January 13, 2020</study_first_submitted>
  <study_first_submitted_qc>January 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 18, 2020</study_first_posted>
  <last_update_submitted>June 7, 2021</last_update_submitted>
  <last_update_submitted_qc>June 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

